Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001209191-21-005731)

Filing Details

Accession Number:
0001209191-21-005731
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-01-27 17:32:18
Reporting Period:
2021-01-25
Accepted Time:
2021-01-27 17:32:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
879169 Incyte Corp INCY Services-Commercial Physical & Biological Research (8731) 943136539
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1624033 Yao Wenqing 1801 Augustine Cut-Off
Wilmington DE 19803		 Evp, Head Of Discovery Chem No Yes No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-01-25 1,559 $73.21 145,343 No 4 M Direct
Common Stock Disposition 2021-01-25 1,559 $100.00 143,784 No 4 S Direct
Common Stock Acquisiton 2021-01-25 19,986 $73.21 163,770 No 4 M Direct
Common Stock Disposition 2021-01-25 19,986 $100.00 143,784 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Show Other Fields >>
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Option (right to buy) Disposition 2021-01-25 1,559 $0.00 1,559 $73.21
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2021-01-25 19,986 $0.00 19,986 $73.21
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2022-01-07 No 4 M Direct
0 2022-01-07 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
  2. This includes an aggregate of 108,222 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested.
  3. Beginning January 8, 2015, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.